Optime Care Recognizes Rare Disease Day, February 28, 2021: Patient-First Strategy Maximizes Therapeutic Treatment for People with Orphan and Rare Disorders

Optime Care Recognizes Rare Disease Day, February 28, 2021: Patient-First Strategy Maximizes Therapeutic Treatment for People with Orphan and Rare Disorders




Optime Care Recognizes Rare Disease Day, February 28, 2021: Patient-First Strategy Maximizes Therapeutic Treatment for People with Orphan and Rare Disorders

EARTH CITY, Mo.–(BUSINESS WIRE)–#RareDiseaseDayOptime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to join national and international efforts to raise awareness about rare diseases and their impact on patients’ lives this Rare Disease Day, February 28. Optime Care’s patient-first approach provides comprehensive, best-in-class services tailored to maximize therapeutic opportunities for people in the rare disease community, including counseling, guidance and education based upon patient and caregiver needs.

“Putting the patient first, the Optime Care approach streamlines patient enrollment, maximizes interaction with patients for adherence and compliance, and provides continuity of care to avoid lapses in therapy — key components of high-quality care, especially during the COVID-19 pandemic,” says Donovan Quill, president and CEO, Optime Care. “Our model also provides exceptional support to caregivers, healthcare providers and biopharma partners, with our experienced team of specialty Rx pharmacists available 24/7 to play a critical role in helping to manage the clinical and non-clinical issues associated with rare diseases.”

Over 300 million people live with one or more of over 6,000 identified rare diseases around the world, each supported by family, friends and a team of caregivers that make up the rare disease community.

“Rare and orphan disease patients require a high level of support and benefit from the high touch service provided by Optime’s care team,” continues Donovan, citing the coordinated activities of the Optime program manager, care coordinator, pharmacist, nurse and specialists. “They are 100% dedicated to the disease state, patient community and therapy – a critical differentiator from other specialty pharmacies and hub service providers, which tend to push technology solutions that fail to address human needs and variability.”

According to Global Genes, a 501(c)(3) nonprofit advocacy organization dedicated to eliminating the burdens and challenges of rare diseases for patients and families globally, the key trends to watch in 2021 for members in each rare community in 2021 include:

  • Data as a driver of progress
  • Nimble development, tailored solutions
  • Aligning policy with paths to progress
  • Leveling the playing field

About Optime Care

Optime Care, Inc. is a nationally recognized pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our management team has previously partnered in the launch and management of more than 40 orphan products and programs and consistently implemented the best brand programs for the community. Our experience with small patient populations makes us uniquely qualified to help every stakeholder group impacted by these disorders. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/

Contacts

Media:
Brittany Tedesco

CPR Communications

btedesco@cpronline.com
201.641.1911 x 14